THERESA HUTCHINGS: Open Payments
NPI 1407237753 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 40 payments from 18 companies in 2025. Trend: 2023 $438 · 2024 $362 · 2025 $1,187
Food & beverage: $1,187
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 7 | $376 |
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $126 |
| Mallinckrodt Hospital Products Inc. | 3 | $99 |
| Lilly USA, LLC | 3 | $79 |
| AKEBIA THERAPEUTICS INC | 2 | $54 |
| HARMONY BIOSCIENCES LLC | 1 | $37 |
| ANI Pharmaceuticals, Inc. | 2 | $33 |
| Ardelyx, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: Xeomin, JARDIANCE, FARXIGA, ACTHAR, Vafseo, WAKIX, PURIFIED CORTROPHIN GEL, IBSRELA.
Industry payments across NY — which companies pay providers there.
